… Citalopram (30 mg/kg) and citalopram (3 mg/kg) with WAY 100,635, which were effective
in the conditioned fear test, did not affect motor activity compared with the vehicle controls. …

… Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and
selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in …

… By contrast, the co-administration of prazosin did not … /kg) of WAY-100635 augmented
anxiolytic-like effects of citalopram, … by an action at alpha 1-adrenoceptors not at 5-HT1A receptors …

… startle response in rats, suggesting that 5-HT 1A receptor-mediated … of the selective 5-HT 1A
receptor antagonist, WAY 100635, could … We propose that the anxiolytic action of 5-HT in the …

… of 5-HT efflux found by the combination of WAY 100635 plus fluoxetine, which effectively …
Invivo it has been shown that both 5-HT1A and 5-HT1B/1D receptor antagonists … GR 127935 16 …

… effects of administration of a selective 5-HT1A receptor antagonist (WAY 100,635) and a
selective 5-HT1B/1D … of the 5-HT1B/1D receptor antagonist did not change the magnitude of the …

… and 5-HT1B/1D receptors. These subtypes are of primary … of WAY 100635, prevents the
reduction in cortical 5-HT release induced by midbrain raphe administration of citalopram, and …

… SB-258719, but not by the 5-HT1A receptor antagonist, WAY-100635, nor the 5-HT1B/1D
receptor antagonist, GR-127935 [61]. The … Co-administration of the selective 5-HT1A receptor …

… 5-HT1A receptor antagonist WAY 100,635, but not the 5-HT1B/1D antagonist GR 127,935.
ese data suggest that … Koyama, “Effect of coadministration of the selective 5-HT1A receptor …

… Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and
selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in …